EPO Patents = 2

Trademarks = 1

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Michael R Loken (5 out of 16 patents)

Sanjaya N Joshi (3 out of 3 patents)

Andrew P Voigt (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12046331 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2024-07-23),

2. 11639936 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2023-05-02),

3. 9880155 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2018-01-30),

4. 8630833 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2014-01-14),

5. 7045295 - Method for collecting purified cells (2006-05-16),

Hematologics, Inc. is a leading biotechnology company specializing in the research and development of innovative therapies for hematologic disorders. With a focus on cutting-edge technology and groundbreaking research, Hematologics is dedicated to improving the lives of patients worldwide. Their team of experts is committed to advancing the field of hematology through their pioneering work in drug discovery and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

5 Patents

#340 in Seattle, WA

#1,190 in Washington

#50,178 in US

Seattle, WA, United States of America

Hematologics, Inc.

Forward Citations = 6

3 inventors:

Michael R Loken (5 out of 16 patents)

Sanjaya N Joshi (3 out of 3 patents)

Andrew P Voigt (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com